| 引用本文: | 王勇,廖淑雯,吴晓明.民营中小医药企业新药研发模式探析[J].中国现代应用药学,2011,28(3):276-280. |
| WANG Yong,LIAO Shuwen,WU Xiaoming.Discussion of the R&D Models for Chinese Private Small and Medium Pharmaceutical Enterprises[J].Chin J Mod Appl Pharm(中国现代应用药学),2011,28(3):276-280. |
|
| 摘要: |
| 目的 探讨现阶段适合我国民营中小医药企业发展的新药研发战略模式。方法 分析我国医药行业和民营中小医药企业研发现状，研究现有的3种研发模式——开拓性创新、模仿创新和完全仿制各自的优劣及所适合的企业类型。结果 通过SWOT分析发现，民营中小医药企业大多具有行为优势，但不具备资源优势，资金、技术以及人力等资源投入都不足。结论 根据民营中小医药企业的综合实力，现阶段选择模仿创新战略更具可行性，可更有效发挥有限资源的使用效率、减小风险；实施过程中要注意选题方向、立项调研评估、专利战略等问题。 |
| 关键词: 研发 模仿创新 开拓性创新 |
| DOI： |
| 分类号: |
| 基金项目: |
|
| Discussion of the R&D Models for Chinese Private Small and Medium Pharmaceutical Enterprises |
|
WANG Yong, LIAO Shuwen, WU Xiaoming
|
|
International Business School of China Pharmaceutical University, Nanjing 210009, China
|
| Abstract: |
| OBJECTIVE To study the R&D models fit for the Chinese private small and medium pharmaceutical enterprises nowadays. METHODS Trough studying the current R&D situation of the Chinese pharmaceutical industry and private small and medium enterprises, this thesis introduced three R&D models, and analyzed their characteristics and applicability for what kinds of enterprise respectively. RESULTS The SWOT analysis showed that most of the private small and medium enterprises had behavioral advantages, but no resources advantages. Their capital, technology and human resource were insufficient. CONCLUSION According to the overall strength of private small and medium enterprises, this thesis suggests that simulating innovation strategy model would be more feasible at this stage. It can enhance the efficiency of limited resources and reduce risk. The enterprises should pay attention to the matters of research project choosing, project evaluation, patent strategy, and etc.. |
| Key words: research and development simulating innovation breakthrough innovation |
